Sanofi SA vs Tractor Supply Co — how do they compare? Sanofi SA trades at $40.04 (market cap $95.18B), while Tractor Supply Co trades at $33.65 (market cap $17.44B). The key difference: Sanofi SA is far larger — about 5.5× Tractor Supply Co's market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Tractor Supply Co for 89 Days on average.
| SNY | TSCO | |
|---|---|---|
Market Cap | $95.18B | $17.44B |
Volume | 2,995,646 | 10,598,723 |
Sector | Health | Consumer Cyclical |
52-Week High | $52.34 | $56.37 |
52-Week Low | $39.51 | $29.14 |
Typical Hold Time | 94 Days | 89 Days |
Enterprise Value | $114.48B | $23.76B |
Dividend Yield | 6.01% | 2.87% |
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
TSCO trades at $33.70, up 3.63% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $15.52B in 2025, though net income margin has declined to 6.42%. Recent earnings missed expectations for three consecutive quarters, and cash flow trends show volatility. The company maintains a strong dividend history, with a 17-year streak of increases, and is expanding distribution infrastructure.
Outlook is mixed: analyst consensus is a Buy with a $36.76 target, but earnings misses and margin pressure pose risks. Upside hinges on operational improvements and rural demand recovery, while competitive pressures and economic cycles remain headwinds for shareholder returns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →